Nifty Pharma
Levels, movements and expert analysis of the Nifty Pharma index. Tracking 4 stories on Arth Vani.
Connected in the graph
Latest on Nifty Pharma
BreakingTrump Tariff Threat Sinks Indian Pharma Stocks; Nifty Pharma Index Falls
Indian pharmaceutical shares declined on Wednesday following US President Trump's announcement of proposed tariffs, including a potential 100% levy, on generic drugs. This move has particularly spooked investors and highlighted the vulnerability of Indian drugmakers with significant revenue exposure to the US market. Analysts are now advising a focus on domestically oriented pharmaceutical firms.
Dr Reddy's Shares Drop 7% as Quality Issues Delay Weight-Loss Drug Launch
Shares of Dr Reddy’s Laboratories witnessed a sharp decline after the company paused commercial supplies of its semaglutide product. The delay stems from quality concerns regarding the active pharmaceutical ingredient (API) used in the drug.
Sun Pharma Shares Slip Below Key Technical Support; Analysts Monitor Short-Term Weakness
India's largest pharmaceutical company, Sun Pharma, has witnessed a technical breakdown as its share price dropped below a critical support level. This movement suggests a potential period of volatility and short-term pressure for retail investors holding the stock.
Sun Pharma Stock Dips: Is This a Buying Opportunity or Sector Warning?
India's largest pharmaceutical company, Sun Pharma, has witnessed a notable decline in its share price over the past month. Investors are now weighing whether this dip represents a value-buying chance or signals a broader slowdown in the pharma sector.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.